Wells Fargo’s Biomerica BMRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-823
| Closed | -$2.89K | – | 6920 |
|
|
2024
Q2 | $2.89K | Sell |
823
-5
| -0.6% | -$25 | ﹤0.01% | 5959 |
|
|
2024
Q1 | $5.51K | Buy |
828
+1
| +0.1% | +$8 | ﹤0.01% | 5872 |
|
|
2023
Q4 | $8.27K | Hold |
827
| – | – | ﹤0.01% | 5879 |
|
|
2023
Q3 | $5.69K | Buy |
827
+2
| +0.2% | +$20 | ﹤0.01% | 5936 |
|
|
2023
Q2 | $8.98K | Buy |
825
+3
| +0.4% | +$36 | ﹤0.01% | 5933 |
|
|
2023
Q1 | $12.3K | Hold |
822
| – | – | ﹤0.01% | 5791 |
|
|
2022
Q4 | $22K | Hold |
822
| – | – | ﹤0.01% | 5217 |
|
|
2022
Q3 | $26K | Buy |
822
+1
| +0.1% | +$26 | ﹤0.01% | 5263 |
|
|
2022
Q2 | $19K | Hold |
821
| – | – | ﹤0.01% | 5471 |
|
|
2022
Q1 | $29K | Hold |
821
| – | – | ﹤0.01% | 5871 |
|
|
2021
Q4 | $25K | Buy |
821
+1
| +0.1% | +$39 | ﹤0.01% | 6253 |
|
|
2021
Q3 | $29K | Sell |
820
-242
| -23% | -$7.96K | ﹤0.01% | 5830 |
|
|
2021
Q2 | $34K | Hold |
1,062
| – | – | ﹤0.01% | 5707 |
|
|
2021
Q1 | $46K | Sell |
1,062
-125
| -11% | -$6.41K | ﹤0.01% | 5845 |
|
|
2020
Q4 | $47K | Sell |
1,187
-2,028
| -63% | -$102K | ﹤0.01% | 5600 |
|
|
2020
Q3 | $178K | Buy |
3,215
+419
| +15% | +$27.1K | ﹤0.01% | 5011 |
|
|
2020
Q2 | $163K | Buy |
2,796
+1,802
| +181% | +$101K | ﹤0.01% | 5013 |
|
|
2020
Q1 | $56K | Buy |
994
+181
| +22% | +$5.52K | ﹤0.01% | 5292 |
|
|
2019
Q4 | $20K | Hold |
813
| – | – | ﹤0.01% | 5740 |
|
|
2019
Q3 | $21K | Hold |
813
| – | – | ﹤0.01% | 5792 |
|
|
2019
Q2 | $17K | Hold |
813
| – | – | ﹤0.01% | 5811 |
|
|
2019
Q1 | $16K | Hold |
813
| – | – | ﹤0.01% | 5567 |
|
|
2018
Q4 | $11K | Hold |
813
| – | – | ﹤0.01% | 5908 |
|
|
2018
Q3 | $23K | Hold |
813
| – | – | ﹤0.01% | 5796 |
|
|
2018
Q2 | $25K | Hold |
813
| – | – | ﹤0.01% | 5765 |
|
|
2018
Q1 | $26K | Hold |
813
| – | – | ﹤0.01% | 5746 |
|
|
2017
Q4 | $24K | Hold |
813
| – | – | ﹤0.01% | 5744 |
|
|
2017
Q3 | $18K | Hold |
813
| – | – | ﹤0.01% | 5735 |
|
|
2017
Q2 | $17K | Hold |
813
| – | – | ﹤0.01% | 5655 |
|
|
2017
Q1 | $14K | Hold |
813
| – | – | ﹤0.01% | 5785 |
|
|
2016
Q4 | $15K | Hold |
813
| – | – | ﹤0.01% | 5691 |
|
|
2016
Q3 | $17K | Buy |
+813
| New | +$17.9K | ﹤0.01% | 5635 |
|
Other funds holding BMRA
GIM
VF
FC
Wells Fargo's BMRA Position: Q3 2024 in Review
Wells Fargo sold out of Biomerica (BMRA) in Q3 2024, closing a stake of 823 shares — an estimated $2.89K sold.
Wells Fargo first reported a position in BMRA in Q3 2016 and held it in 32 quarters. The position peaked at $178K in Q3 2020. 25 funds tracked by Wall St. Rank hold BMRA as of Q3 2024.
- Wells Fargo reported no remaining Biomerica position as of Q3 2024 after selling out during the quarter.
- Wells Fargo sold 823 Biomerica shares in Q3 2024, an estimated $2.89K.
- Wells Fargo first reported a position in Biomerica in Q3 2016 and held it in 32 quarters.
- Wells Fargo's Biomerica position peaked at $178K in Q3 2020.
- 25 funds tracked by Wall St. Rank held Biomerica as of Q3 2024.
Based on Wells Fargo's 13F filing for Q3 2024, filed 13 Nov 2024.